Shopping Cart
Remove All
Your shopping cart is currently empty
Penpulimab is a monoclonal antibody targeting PD-1 with antitumor activity, used in studies of pancreatic cancer.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $89 | In Stock | In Stock | |
| 5 mg | $222 | In Stock | In Stock | |
| 10 mg | $347 | - | In Stock | |
| 25 mg | $590 | - | In Stock | |
| 50 mg | $856 | - | In Stock |
| Description | Penpulimab is a monoclonal antibody targeting PD-1 with antitumor activity, used in studies of pancreatic cancer. |
| In vitro | Penpulimab is an IgG1 anti-PD-1 monoclonal antibody with anti-tumor activity. Penpulimab significantly increased the levels of IL-2 and IFN-γ produced by peripheral blood mononuclear cells (PBMC). [1] |
| In vivo | Penpulimab (5 mg/kg intraperitoneally administered twice a week for three weeks) inhibits tumor growth. [2] |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Host Species | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Uniprot ID |
| Cas No. | 2350298-92-7 |
| Color | Transparent |
| Appearance | Liquid |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.